Light-based Immunomodulation for Guarding Against Human Respiratory Tract Infections
Status: Recruiting
Location: See location...
Intervention Type: Device
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY
The purpose of trial is to determine if daily usage of a photobiomodulation device will decrease the incidence of upper respiratory tract infections (URI) due to COVID, influenza or other viruses.The RD-X10 device is handheld, can be self-administered, and has been shown to be safe in invivo studies.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: t
View:
• Active Duty and DoD Beneficiaries (i.e. former military, spouse, dependent child) aged 18 years and older who work in the Mike O'Callaghan Military Medical Center at Nellis Air Force Base.
Locations
United States
Nevada
Mike O'Callaghan Military Medical Center
RECRUITING
Nellis Air Force Base
Contact Information
Primary
Sandra Huffman
Sandra.g.huffman.ctr@health.mil
7026533583
Time Frame
Start Date: 2026-10-01
Estimated Completion Date: 2028-06
Participants
Target number of participants: 130
Treatments
Experimental: Group 1: Active RD-X19 every other day for 3 months
Sham_comparator: Group 2: Sham RD-X19 every other day for 3 months
Related Therapeutic Areas
Sponsors
Leads: David Moss